Clinical Trial Update: Decidual Stromal Cells as Treatment for Acute Graft Versus Host Disease, a Phase 1-2 Study [Phase 1, Phase 2]

View source ↗

Summary

Phase 1-2 clinical trial evaluating decidual stromal cells for the treatment of acute graft-versus-host disease; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Decidual stromal cells

Snippet

Sponsor: Karolinska Institutet | Conditions: Graft vs Host Disease | Phase 1, Phase 2 | Status: UNKNOWN